electroCore (ECOR) Depreciation and Depletion (2018 - 2019)
electroCore's quarterly Depreciation and Depletion came in at $27480.0 in Q4 2019, up 10.2% year-on-year from $24936.0 in Q4 2018, and little changed quarter-over-quarter from $27366.0 in Q3 2019.
electroCore has reported Depreciation and Depletion for 2 years, with the latest figure at $27480.0 in Q4 2019.
- For the quarter ending Q4 2019, Depreciation and Depletion rose 10.2% year-over-year to $27480.0; the trailing twelve-month figure through Dec 2019 stood at $100445.0 (changed N/A YoY), and the FY2019 full-year result was $108546.0, up 62.83% from the prior year.
- Depreciation and Depletion for Q4 2019 stood at $27480.0, roughly flat from $27366.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $27480.0 in Q4 2019, with the low at $20663.0 in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 308.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 29.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 27,480.00 |
| Dec 31, 2019 | 27,480.00 |
| Sep 30, 2019 | 27,366.00 |
| Sep 30, 2019 | 27,366.00 |
| Dec 31, 2018 | 24,936.00 |
| Dec 31, 2018 | 24,936.00 |
| Sep 30, 2018 | 20,663.00 |
| Sep 30, 2018 | 20,663.00 |